Pentech Pharmaceuticals, Inc.
Records under this name other than patents Pentech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Pentech Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,193,992 | Female sexual dysfunction treatment Lapsed on the fee record Ended Feb 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Feb 27, 2013 | From the USPTO record |
| US 6,660,298 | Paroxetine tablets and capsules Lapsed on the fee record Ended Dec 9, 2011 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2011 | From the USPTO record |
| US 6,638,948 | Amorphous paroxetine composition Lapsed on the fee record Ended Oct 28, 2011 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2011 | From the USPTO record |
| US 6,306,437 | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction Lapsed on the fee record Ended Oct 23, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2009 | From the USPTO record |
| US 6,200,983 | Dosage forms containing apomorphine for ameliorating male erectile dysfunction Lapsed on the fee record Ended Mar 13, 2009 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2009 | From the USPTO record |
| US 6,121,276 | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction Lapsed on the fee record Ended Sep 19, 2008 · From the USPTO record | Lapsed on the fee record | Ended Sep 19, 2008 | From the USPTO record |
| US 6,087,362 | Apomorphine and sildenafil composition Lapsed on the fee record Ended Jul 11, 2008 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2008 | From the USPTO record |
| US 6,566,368 | Apomorphine-containing dosage form for ameliorating male erectile dysfunction Lapsed on the fee record Ended May 20, 2007 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2007 | From the USPTO record |
| US 6,503,927 | Amorphous paroxetine composition Lapsed on the fee record Ended Jan 7, 2007 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2007 | From the USPTO record |
| US 5,562,917 | Transdermal administration of apomorphine Term ended Term ended no later than Oct 8, 2016 · Low confidence | Term ended | Term ended no later than Oct 8, 2016 | Low confidence |